These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17610704)

  • 1. Statistical rigour is essential to clinical prediction.
    Gebski VJ; Byth K; Langlands AO
    ANZ J Surg; 2007 Jul; 77(7):597-8; author reply 598-9. PubMed ID: 17610704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 3. Scoring systems for the prediction of non-sentinel node metastasis in breast cancer patients.
    Barranger E; Morel O; Coutant C
    Am J Surg; 2008 Nov; 196(5):799-800. PubMed ID: 18353276
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant tuberculosis and metastasis in axillary lymph nodes: a diagnostic surprise.
    Gaurav M; Rajgopal S; Mary M; Bhavatej E
    ANZ J Surg; 2008 Sep; 78(9):825-6. PubMed ID: 18844925
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer with positive sentinel lymph node: now what?
    Morris GJ; Berger AC; Emanuelson RG; Jordan WE; McGuire K; Thomas LC
    Semin Oncol; 2009 Apr; 36(2):84-9. PubMed ID: 19332242
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncertainty and the value of diagnostic information, with application to axillary lymph node dissection in breast cancer.
    Parmigiani G
    Stat Med; 2004 Mar; 23(5):843-55. PubMed ID: 14981678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternaria simulating metastatic breast carcinoma in cytokeratin-stained axillary sentinel node sections.
    Robinson BD; Amin BD; Hoda SA
    Breast J; 2008; 14(1):120-1. PubMed ID: 18186881
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers.
    Chen JH; Agrawal G; Carpenter P; Mehta RS; Nalcioglu O; Su MY
    Ann Surg Oncol; 2008 Mar; 15(3):941-2. PubMed ID: 18004624
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience.
    Poirier E; Sideris L; Dubé P; Drolet P; Meterissian SH
    Ann Surg Oncol; 2008 Sep; 15(9):2562-7. PubMed ID: 18618183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
    Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
    Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lymph node positivity in multifocal and multicentric breast cancer.
    Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
    J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer--a potential diagnostic pitfall.
    Millar EK; Inder S; Lynch J
    Histopathology; 2009 Apr; 54(5):622-3. PubMed ID: 19413641
    [No Abstract]   [Full Text] [Related]  

  • 14. Paracortical axillary sentinel lymph node ectopic breast tissue.
    Zynger DL; McCallum JC; Everton MJ; Yeldandi AV; Susnik B
    Pathol Res Pract; 2009; 205(6):427-32. PubMed ID: 19168294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new era in breast cancer.
    Shetty MR
    Arch Surg; 1996 Jul; 131(7):788. PubMed ID: 8678785
    [No Abstract]   [Full Text] [Related]  

  • 16. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled clinical trial on sentinel node lymph node dissection versus axillary lymph node dissection: a matter of technique or patient selection?
    Carmichael AR
    Ann Surg; 2008 Nov; 248(5):895; author reply 895-6. PubMed ID: 18948821
    [No Abstract]   [Full Text] [Related]  

  • 18. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
    Pervez S; Khan MN; Nasir MI
    J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast (Br J Surg 2008; 95: 547-554).
    Meijnen P; Rutgers EJ
    Br J Surg; 2008 Oct; 95(10):1305; author reply 1305. PubMed ID: 18763257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.